Procter & Gamble Company (The) $PG Shares Bought by Humankind Investments LLC

Humankind Investments LLC raised its stake in Procter & Gamble Company (The) (NYSE:PGFree Report) by 1.8% in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 37,515 shares of the company’s stock after acquiring an additional 680 shares during the quarter. Procter & Gamble makes up 1.7% of Humankind Investments LLC’s portfolio, making the stock its 11th biggest holding. Humankind Investments LLC’s holdings in Procter & Gamble were worth $6,393,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors also recently made changes to their positions in PG. Navigoe LLC acquired a new position in shares of Procter & Gamble in the fourth quarter worth $31,000. Capital A Wealth Management LLC acquired a new position in shares of Procter & Gamble in the fourth quarter worth $31,000. 10Elms LLP acquired a new position in shares of Procter & Gamble in the fourth quarter worth $34,000. Sunbeam Capital Management LLC acquired a new position in shares of Procter & Gamble in the fourth quarter worth $34,000. Finally, Mizuho Securities Co. Ltd. raised its holdings in shares of Procter & Gamble by 566.7% in the first quarter. Mizuho Securities Co. Ltd. now owns 200 shares of the company’s stock worth $34,000 after acquiring an additional 170 shares during the last quarter. 65.77% of the stock is owned by institutional investors and hedge funds.

Procter & Gamble Price Performance

PG stock opened at $158.3090 on Wednesday. The stock has a 50-day moving average price of $156.97 and a two-hundred day moving average price of $163.13. Procter & Gamble Company has a 12-month low of $149.91 and a 12-month high of $180.43. The company has a current ratio of 0.70, a quick ratio of 0.49 and a debt-to-equity ratio of 0.49. The company has a market cap of $370.82 billion, a PE ratio of 24.32, a price-to-earnings-growth ratio of 4.11 and a beta of 0.37.

Procter & Gamble (NYSE:PGGet Free Report) last posted its quarterly earnings results on Tuesday, July 29th. The company reported $1.48 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.42 by $0.06. Procter & Gamble had a return on equity of 32.69% and a net margin of 18.95%.The firm had revenue of $20.89 billion during the quarter, compared to the consensus estimate of $20.79 billion. During the same quarter in the previous year, the business earned $1.40 earnings per share. The firm’s quarterly revenue was up 1.7% compared to the same quarter last year. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. As a group, research analysts predict that Procter & Gamble Company will post 6.91 EPS for the current year.

Procter & Gamble Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, August 15th. Stockholders of record on Friday, July 18th were given a $1.0568 dividend. The ex-dividend date of this dividend was Friday, July 18th. This represents a $4.23 annualized dividend and a dividend yield of 2.7%. Procter & Gamble’s dividend payout ratio is presently 64.98%.

Wall Street Analysts Forecast Growth

Several equities analysts recently commented on the company. Citigroup dropped their target price on Procter & Gamble from $200.00 to $181.00 and set a “buy” rating for the company in a research note on Friday, April 25th. BNP Paribas reiterated an “outperform” rating and issued a $177.00 target price on shares of Procter & Gamble in a research note on Friday, August 15th. Erste Group Bank lowered Procter & Gamble from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, April 30th. Royal Bank Of Canada upgraded Procter & Gamble from a “sector perform” rating to an “outperform” rating and upped their target price for the company from $164.00 to $177.00 in a research note on Friday, April 25th. Finally, UBS Group set a $180.00 target price on Procter & Gamble and gave the company a “buy” rating in a research note on Wednesday, July 30th. Two investment analysts have rated the stock with a Strong Buy rating, eleven have given a Buy rating and seven have issued a Hold rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $175.94.

View Our Latest Stock Report on Procter & Gamble

About Procter & Gamble

(Free Report)

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.

Featured Articles

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PGFree Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.